Roivant Sciences
Price & Volume
Stats
See moreOpen | $20.38 |
Previous Close | $20.30 |
Day Range | $20.29-$20.54 |
52W Range | $8.73-$21.35 |
Market Cap | $14B |
Shares Short | 24M |
Financials
See moreRevenue (12 Mos) | $20.3M |
Revenue Growth (YoY) | -64.9% |
Gross Profit (12 Mos) | -$581.7M |
Diluted EPS | -$0.99 |
News
See moreYahoo Finance • 15 days ago
Roivant Sciences GAAP EPS of -$0.17 beats by $0.16, revenue of $1.57M misses by $5.35M
Yahoo Finance • 15 days ago
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update
Yahoo Finance • 18 days ago
Pre-Market Earnings Report for November 10, 2025 : B, B, TSN, ROIV, KSPI, TSEM, MNDY, CART, STWD, RDNT, BEKE, BXSL
Yahoo Finance • 18 days ago
Roivant Sciences Q2 2026 Earnings Preview
About
CEO | Mr. Matthew Gline |
Address | 11-12 St. James's Square, London, United Kingdom, SW1Y 4LB |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 750 |
